# Module 1.4: End-to-End Integration & Final Validation Report

**Project**: Nephron-Aware Renal Digital Twin  
**Milestone**: M1.4 End-to-End Integration and Validation  
**Parent Artifact**: Validated M1.2 Phase B Cohort (`data/processed/cohort_renal_bounded.csv`)  
**Status**: PASS  
**Date (UTC)**: 2026-10-19T17:35:24.605292+00:00  
**Execution Runtime**: 24.75 seconds  

---

## 1. Executive Summary & Verification Verdict

Module 1.4 executes the final end-to-end integration and verification harness synthesizing all completed modules of Phase 1:
- **M1.1 Dataset Audit**: Preserved raw source integrity, d_labitems renal dictionary, and item discovered profile.
- **M1.2 Phase B Cohort Extraction & WEKA Benchmark**: Validated 2,500 patient renal cohort, complete demographic and admission linkages, unit harmonization, and deterministic benchmark parity.
- **M1.3 Canonical Schema, Conflict Arbitration, Temporal Features, & Three-Way Pipeline**:
  - Canonical conversion and strict schema validation.
  - Policy A (Operational Storetime Precedence) exact arbitration audit on the full 303,460-row cohort.
  - Irregular biological velocity and unequal-interval acceleration derivation without zero-gap singularities.
  - Dual-timeline operational query-time availability filtration without lookahead or retroactive rewriting.
  - Dynamic negative control validation exposing historical leakage, patient bleed, and outpatient loss.

### Final Verification Verdict: **PASS**

All automated verification gates passed with zero regressions, full mathematical reproducibility, and exact alignment between empirical code outputs and published milestone reports.

---

## 2. Comprehensive Verification Gates

| Verification Gate | Target Standard / Invariant | Empirical Observed | Status |
| :--- | :--- | :--- | :--- |
| **Cohort File Presence** | File exists and readable | `data\processed\cohort_renal_bounded.csv` (69,862,115 bytes) | **PASS** |
| **Cohort Row Count** | Exactly 303,460 rows | `303,460` | **PASS** |
| **Cohort Patient Count** | Exactly 2,500 distinct patients | `2,500` | **PASS** |
| **Cohort Column Count** | Exactly 30 canonical/demographic columns | `30` | **PASS** |
| **Cohort Artifact Hash** | SHA-256 reference integrity check | `9534adfda88896433cae38e87efcd66008bf558595a5734d5251181a615b4d35` | **PASS** |
| **Arbitration Total Input** | Exactly 303,460 rows | `303,460` | **PASS** |
| **Arbitration Total Output** | Exactly 303,460 rows (zero row loss) | `303,460` | **PASS** |
| **Arbitration Active Records** | Exactly 303,232 active events (`PRIMARY_SELECTED`) | `303,232` | **PASS** |
| **Arbitration Superseded Duplicates** | Exactly 94 superseded duplicates (`SUPERSEDED_DUPLICATE`) | `94` | **PASS** |
| **Arbitration Superseded Conflicts** | Exactly 134 superseded conflicts (`SUPERSEDED_CONFLICT`) | `134` | **PASS** |
| **Total Superseded Records** | Exactly 228 superseded records (94 + 134) | `228` | **PASS** |
| **Mixed `hadm_id` Collisions** | Zero cross-admission collision groups | `0` | **PASS** |
| **Operational Lookahead Gate** | Draw at 10:00, filed at 12:30: absent at 11:00, present at 12:30 | Absent at 11:00 (`True`), Present at 12:30 (`True`) | **PASS** |
| **Operational Immutability Gate** | Later arrivals never alter historical snapshots | Immutable snapshot replay: `True` | **PASS** |
| **Co-temporal Ratio Gating** | BUN/Cr computed only on co-temporal epochs with delay >= 0 | Epoch 1 valid (`True`), Epoch 2 NaN (`True`) | **PASS** |
| **Patient Boundary Isolation** | Elapsed time and rolling deltas reset at boundary | Patient B elapsed=0.0 (`True`), delta=NaN (`True`) | **PASS** |
| **Control 2A (Normalization Leakage)** | Future extreme causes measurable historical drift | Leakage detected: `True` (Drift: `41.500000`) | **PASS** |
| **Control 2B (Patient Delta Bleed)** | Cross-patient boundary calculation causes error | Bleed detected: `True` (Delta: `86910.55`) | **PASS** |
| **Control 2C (Admissions Join Loss)** | Inner join drops outpatient records | 103,354 rows (34.0585%), 378 patients (378 pts) | **PASS** |

---

## 3. Full-Cohort Arbitration Accounting Audit

Under Policy A (`POLICY_A_STORETIME`), duplicate and conflicting laboratory measurements are arbitrated using operational EHR filing precedence, deterministic tie-breaking by lowest `labevent_id`, and full provenance preservation.

```
Total Bounded Cohort Input Rows:            303,460
├── Active Effective Records (Primary):     303,232 (99.9249%)
└── Superseded Retained Records:                228 ( 0.0751%)
    ├── Superseded Exact Duplicates:             94 ( 0.0310%) [41.23% of collisions]
    └── Superseded Conflicts:                   134 ( 0.0442%) [58.77% of collisions]
Total Output Rows (Zero Data Loss):         303,460 (100.000%)
```

- **Runtime for Full Cohort Arbitration**: `1.50 seconds` on 303,460 rows.
- **Exact Collision Disjointness**: 0 rows belong to both duplicate and conflicting categories.
- **Traceability Guarantee**: Every superseded record is linked to its primary counterpart via `superseded_by_labevent_id` and tagged with `is_primary_effective=False`.

---

## 4. Dual-Timeline Engine & Operational Invariant Verification

The dual-timeline engine enforces absolute separation between retrospective biological trajectories and real-time operational availability:

1. **Biological Timeline ($F_{bio}$)**:
   - Driven strictly by specimen draw time (`charttime`).
   - Explicitly tagged as `is_retrospective_only = True` (non-deployable for live clinical alerts).
   - Generates non-uniform velocity $\Delta v / \Delta t$ and unequal-interval acceleration $\Delta a / \Delta t$ without zero-gap singularities.

2. **Operational Timeline ($F_{ops}$)**:
   - Evaluated at explicit availability-snapshot query times $t_{query}$.
   - Visibility filter: `storetime <= t_query AND delay_anomaly_flag != 'NEGATIVE_REPORTING_DELAY'`.
   - Results with `storetime > t_query` are mathematically inaccessible.
   - Rates calculated on `storetime` differences are documented as reporting-arrival velocity, never inferred as physiological dynamics.
   - **Empirical Snapshot Replay Test**:
     * Specimen drawn at 10:00:00, filed at 12:30:00.
     * Snapshot at 11:00:00: 0 visible events (result completely absent).
     * Snapshot at 12:30:00: 1 visible event (result available).
     * Snapshot re-query at 11:00:00: Identical byte-for-byte representation (immutable, no retroactive rewriting).

---

## 5. Three-Way Representation Baseline Divergence

On a standardized 5,000-row integration benchmark across Arms 1, 2, and 3:

| Integrity Metric | Arm 1 (Conventional 24h Grid) | Arm 2 (Flawed Controls) | Arm 3 (Proposed Dual-Timeline) |
| :--- | :--- | :--- | :--- |
| **Grid Resampling Expansion** | `46,495` daily steps (4,712 days) | N/A (unaligned) | 4,978 active irregular events |
| **Intra-Day Observation Collapse** | **266 rows lost** to daily mean | N/A | **0 rows lost (100% preserved)** |
| **Future Normalization Leakage** | 0.0 (per-patient local) | **0.650802 historical drift** | **0.0 (strictly causal)** |
| **Cross-Patient Boundary Bleed** | 0 violations (resets enforced) | **Bleed Detected (Delta: 14949.33)** | **0 violations (strict isolation)** |
| **Outpatient Record Loss** | 0 rows lost (left joins) | **2,436 rows lost (48.72%)** | **0 rows lost (100% retained)** |
| **Zero-Gap Singularities** | N/A (discrete day grid) | N/A | **0 (co-temporal epoch grouped)** |
| **Operational Lookahead Violations** | N/A (retrospective daily) | N/A | **0 (strict query-time filtering)** |

---

## 6. System Execution Benchmark & Runtime Profile

- **Complete Test Suite**: 87 passing tests in 22.52 seconds.
- **Cohort File Hash Verification**: 9534adfda8889643... verified in < 0.25 seconds.
- **Full Cohort Arbitration (303,460 rows)**: 1.50 seconds.
- **Overall End-to-End Acceptance Harness**: 24.75 seconds.
- **Zero Raw Modifications**: Raw source directory (`data/raw`) remains immutable and untouched.

---

## 7. Sign-Off & Transition to Phase 2

All milestone requirements for Module 1 (Data Foundation, Representation, and Audit) are hereby fulfilled:
1. Module 1.1 Dataset Audit: Completed and frozen.
2. Module 1.2 Phase B Cohort & WEKA Comparison: Completed and frozen.
3. Module 1.3 Canonical Schema, Arbitration, Features, & 3-Way Audit: Completed and frozen.
4. Module 1.4 End-to-End Integration & Verification: **OFFICIALLY ACCEPTED**.

The data pipeline is fully ready for **Phase 2: Digital Twin Modeling & Nephron-Aware Differential Equations**.
